Are all 'sharks' dangerous? New biotechnology ventures and partner selection in R&D alliances

Strategic Management Journal

Volumn 33, Issue 10, 2012, Pages 1115-1134

  Diestre, Luis ^a   Rajagopalan, Nandini ^b  

^a IE BUSINESS SCHOOL   (Spain)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

biopharmaceutical industry; innovation; new ventures; R D alliances; value creation and value appropriation

Indexed keywords

BIOPHARMACEUTICAL INDUSTRY; BIOTECHNOLOGY FIRMS; CONTEXTUAL FACTORS; EMPIRICAL FINDINGS; NEW VENTURES; PARTNER SELECTION; PHARMACEUTICAL FIRMS; POTENTIAL PARTNERS; THEORETICAL FRAMEWORK; VALUE CREATION;

BIOTECHNOLOGY; INNOVATION;

INDUSTRY;

EID: 84865104816     PISSN: 01432095     EISSN: 10970266     Source Type: Journal    
DOI: 10.1002/smj.1978     Document Type: Article

References (58)

1. Adegbesan JA, Higgins MJ,. 2011. The intra-alliance division of value created through collaboration. Strategic Management Journal 32 (2): 187-211.
2. Ahuja G,. 2000. The duality of collaboration: inducements and opportunities in the formation of interfirm linkages. Strategic Management Journal, March Special Issue 21: 317-343.
3. Ahuja G, Katila R,. 2001. Technological acquisitions and the innovation performance of acquiring firms: a longitudinal study. Strategic Management Journal 22 (3): 197-220.
4. Ai C, Norton EC,. 2003. Interaction terms in logit and probit models. Economics Letters 80: 123-129.
5. Aiken LS, West SG,. 1991. Multiple Regression: Testing and Interpreting Interactions. Sage Publications: Newbury Park, CA.
6. Alvarez SA, Barney JB,. 2001. How entrepreneurial firms can benefit from alliances with large partners. Academy of Management Executive 15: 139-148.
7. Arora A, Gambardella A,. 1994. Evaluating technological information and utilizing it: scientific knowledge, technological capability and external linkages in biotechnology. Journal of Economic Behavior and Organization 24: 91-114.
8. Baum JAC, Calabrese T, Silverman BS,. 2000. Don't go it alone: alliance network composition and startups' performance in Canadian biotechnology. Strategic Management Journal, March Special Issue 21: 267-294.
9. Biotechnology Innovation Report. 2005. Finnegan, Henderson, Farabow, Garrett & Dunner, LLP: Washington, D.C.
10. Cockburn IM, Henderson RM,. 2001. Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research. Journal of Health Economics 20: 1033-1057.
11. Cohen WM, Levinthal DA,. 1990. Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly, 35: 128-152.
12. Colombo MG, Grilli L, Piva E,. 2006. In search of complementary assets: the determinants of alliance formation of high-tech start-ups. Research Policy 35: 1166-1199.
13. Durand R, Bruyaka O, Mangematin V,. 2008. Do science and money go together? The case of the French biotech industry. Strategic Management Journal 29 (12): 1281-1299.
14. Dushnitsky G, Lenox MJ,. 2005a. When do firms undertake R&D by investing in new ventures? Strategic Management Journal 26 (10): 947-965.
15. Dushnitsky G, Lenox MJ,. 2005b. When do incumbents learn from entrepreneurial ventures? Corporate venture capital and investing firm innovation rates. Research Policy 34: 615-639.
16. Dushnitsky G, Shaver JM,. 2009. Limitations to interorganizational knowledge acquisition: the paradox of corporate venture capital. Strategic Management Journal 30 (10): 1045-1064.
17. Giovannetti GT, Morrison SW,. 2000. Convergence: The Biotechnology Industry Report. Ernst & Young: Palo Alto, CA.
18. Greene WH,. 2003. Econometric Analysis (3rd edn). Prentice Hall: Englewood Cliffs, NJ.
19. Gulati R,. 1995. Social structure and alliance formation patterns: a longitudinal analysis. Administrative Science Quarterly 40: 619-652.
20. Hall BH, Jaffe AB, Trajtenberg M,. 2001. The NBER patent citations data file: lessons, insights and methodological tools. NBER Working paper no. 8498. National Bureau of Economic Research: Cambridge, MA.
21. Heckman J,. 1979. Sample selection bias as a specification error. Econometrica 47: 153-161.
22. Henderson R, Cockburn I,. 1994. Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal, Winter Special Issue 15: 63-84.
23. Hoang H, Rothaermel FT,. 2005. The effect of general and partner-specific alliance experience on joint R&D project performance. Academy of Management Journal 48: 332-345.
24. Hoetker G,. 2007. The use of logit and probit models in strategic management research: critical issues. Strategic Management Journal 28 (4): 331-343.
25. Inkpen AC,. 2000. A note on the dynamics of learning alliances: competition, cooperation, and relative scope. Strategic Management Journal 21 (7): 775-779.
26. Katila R, Ahuja G,. 2002. Something old, something new: a longitudinal study of search behavior and new product introduction. Academy of Management Journal 45 (6): 1183-1194.
27. Katila R, Mang PY,. 2003. Exploiting technological opportunities: the timing of collaborations. Research Policy 32: 317-332.
28. Katila R, Rosenberg JD, Eisenhardt KM,. 2008. Swimming with sharks: technology ventures and corporate relationships. Administrative Science Quarterly 53: 295-332.
29. Khanna T,. 1998. The scope of alliances. Organization Science 9: 340-355.
30. Khanna T, Gulati R, Nohria N,. 1998. The dynamics of learning alliances: competition, cooperation, and relative scope. Strategic Management Journal 19 (3): 193-210.
31. Lane PJ, Lubatkin MH,. 1998. Relative absorptive capacity and interorganizational learning. Strategic Management Journal 19 (5): 461-477.
32. Lanjouw JO, Schankerman M,. 2001. Enforcing intellectual property rights. NBER Working paper no. 8656. National Bureau of Economic Research: Cambridge, MA.
33. Lavie D,. 2007. Alliance portfolios and firm performance: a study of value creation and appropriation in the U.S. software industry. Strategic Management Journal 28 (12): 1187-1212.
34. Li D, Eden L, Hitt MA, Ireland RD,. 2008. Friends, acquaintances or strangers? Partner selection in R&D alliances. Academy of Management Journal 51: 315-334.
35. Liang KY, Zeger SL,. 1986. Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22.
36. Macher JT, Boerner CS,. 2006. Experience and scale and scope economies: trade-offs and performance in development. Strategic Management Journal 27 (9): 845-865.
37. Matraves C,. 1999. Market structure, R&D and advertising in the pharmaceutical industry. Journal of Industrial Economics 42: 169-194.
38. Miller DJ,. 2004. Firms' technological resources and the performance effects of diversification: a longitudinal study. Strategic Management Journal 25 (11): 1097-1119.
39. Mowery DC, Oxley JE, Silverman BS,. 1996. Technological overlap and interfirm cooperation: implications for the resource-based view of the firm. Research Policy 27: 507-523.
40. Nerkar A, Roberts PW,. 2004. Technological and product-market experience and the success of the new product introductions in the pharmaceutical industry. Strategic Management Journal, August-September Special Issue 25: 779-799.
41. Oxley JE,. 1997. Appropriability hazards and governance in strategic alliances: a transaction cost approach. Journal of Law, Economics and Organization 13: 387-409.
42. Oxley JE, Sampson RC,. 2004. The scope and governance of international R&D alliances. Strategic Management Journal, August-September Special Issue 25: 723-749.
43. PhRMA. 2007. PhRMA R&D Report. Pharmaceutical Research and Manufacturers of America (PhRMA): Washington, DC.
44. Pisano GP,. 1991. The governance of innovation: vertical integration and collaborative arrangements in the biotechnology industry. Research Policy 20: 237-249.
45. Pisano GP,. 1997. R&D performance, collaborative arrangements and the market for know-how: a test of the 'lemons' hypothesis in biotechnology. SSRN working paper. Available at: http://ssrn.com/abstract=41980 (accessed 20 March 2012).
46. Reuer JJ, Ariño A,. 2007. Strategic alliance contracts: dimensions and determinants of contractual complexity. Strategic Management Journal 28 (3): 313-330.
47. Reuer JJ, Zollo M,. 2005. Termination outcomes of research alliance. Research Policy 34: 101-115.
48. Reuer JJ, Zollo M, Singh H,. 2002. Post-formation dynamics in strategic alliances. Strategic Management Journal 23 (2): 135-151.
49. Rosenkopf L, Almeida P,. 2003. Overcoming local search through alliances and mobility. Management Science 49: 751-766.
50. Rothaermel FT,. 2001. Incumbent's advantage through exploiting complementary assets via interfirm cooperation. Strategic Management Journal, June-July Special Issue 22: 687-699.
51. Rothaermel FT, Boeker W,. 2008. Old technology meets new technology: complementarities, similarities, and alliance formation. Strategic Management Journal 29 (1): 47-77.
52. Rothaermel FT, Deeds DL,. 2004. Exploration and exploitation alliances in biotechnology: a system of new product development. Strategic Management Journal 25 (3): 201-221.
53. Sampson R,. 2007. R&D alliances and firm performance: the impact of technological diversity and alliance organization on innovation. Academy of Management Journal 50: 364-386.
54. Shan W, Walker G, Kogut B,. 1994. Interfirm cooperation and startup innovation in the biotechnology industry. Strategic Management Journal 15 (5): 387-394.
55. Stuart TE,. 1998. Network positions and propensities to collaborate: an investigation of strategic alliance formation in a high-technology industry. Administrative Science Quarterly 43: 668-698.
56. Teece DJ,. 1992. Competition, cooperation, and innovation: organizational arrangements for regimes of rapid technological progress. Journal of Economic Behavior and Organization 18: 1-25.
57. Wiersema MF, Bowen HP,. 2009. The use of limited dependent variable techniques in strategy research: issues and methods. Strategic Management Journal 30 (6): 679-692.
58. Wooldridge JM,. 2002. Econometric Analysis of Cross Section and Panel Data (1st edn). MIT Press: Cambridge, MA.